Lack of CB1 receptor activity impairs serotonergic negative feedback

Journal of Neurochemistry

Volumn 109, Issue 3, 2009, Pages 935-944

  Aso, Ester ^a   Renoir, Thibault ^b   Mengod, Guadalupe ^c   Ledent, Catherine ^d   Hamon, Michel ^b   Maldonado, Rafael ^a   Lanfumey, Laurence ^b   Valverde, Olga ^a  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b INSERM   (France)

^c INST D INVESTIGACIONS B   (Spain)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

5 HT; 5 HT1A; 5 HT2C; 5 HTT; CB1 cannabinoid receptor

Indexed keywords

CANNABINOID 1 RECEPTOR; FLUOXETINE; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2B RECEPTOR; SEROTONIN 2C RECEPTOR; SEROTONIN RECEPTOR; CITALOPRAM; SEROTONIN TRANSPORTER; SEROTONIN UPTAKE INHIBITOR; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DORSAL RAPHE NUCLEUS; DRUG MECHANISM; GENE OVEREXPRESSION; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BINDING; THALAMUS MIDLINE NUCLEUS; ANIMAL; AREA UNDER THE CURVE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; EXTRACELLULAR FLUID; FEEDBACK SYSTEM; GENE EXPRESSION; GENETICS; HIPPOCAMPUS; METABOLISM; METHODOLOGY; MICRODIALYSIS; MOUSE MUTANT; NERVE CELL; PHYSIOLOGY; RAPHE NUCLEUS;

MUS;

ANIMALS; AREA UNDER CURVE; CITALOPRAM; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; FEEDBACK, BIOCHEMICAL; FLUOXETINE; GENE EXPRESSION; HIPPOCAMPUS; MALE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; NEURONS; PREFRONTAL CORTEX; PROTEIN BINDING; RAPHE NUCLEI; RECEPTOR, CANNABINOID, CB1; RECEPTOR, SEROTONIN, 5-HT2C; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEROTONIN UPTAKE INHIBITORS; TRITIUM;

EID: 64149092816     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06025.x     Document Type: Article

References (52)

1. Artigas F., Nutt D. J. Shelton R. (2002) Mechanism of action of antidepressants. Psychopharmacol. Bull. 36, 123 132.
2. 1 knockout mice. J. Neurochem. 105, 565 572.
3. Bambico F. R., Katz N., Debonnel G. Gobbi G. (2007) Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex. J. Neurosci. 27, 11700 11711.
4. 1A autoreceptors after chronic unpredictable stress. Eur. Neuropsychopharmacol. 19, 215 228.
5. Barnes N. M. Sharp T. (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38, 1083 1152.
6. Berton O. Nestler E. J. (2006) New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7, 137 151.
7. Best A. R. Regehr W. G. (2008) Serotonin evokes endocannabinoid release and retrogradely suppresses excitatory synapses. J. Neurosci. 28, 6508 6515.
8. 2B/C receptors regulate 5-HT cell firing in the dorsal raphe nucleus of the anaesthetised rat. Br. J. Pharmacol. 139, 998 1004.
9. (2C) receptors inhibit 5-HT neuronal activity via a GABAergic mechanism. Br. J. Pharmacol. 149, 861 869.
10. Caspi A., Sugden K., Moffitt T. E. et al. (2003) Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 301, 386 389.
11. Charney D. S. (1998) Monoamine dysfunction and the pathophysiology and treatment of depression. J. Clin. Psychiatry 59, 11 14.
12. Cota D. (2008) The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol. 20 (Suppl. 1 35 38.
13. Cota D., Marsicano G., Tschöp M. et al. (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J. Clin. Invest. 112, 423 431.
14. 1A receptor sensitivity in major depression. A neuroendocrine study with buspirone. Br. J. Psychiatry 164, 372 379.
15. Cremers T. I., Giorgetti M., Bosker F. J. et al. (2004) Inactivation of 5-HT(2C) receptors potentiates consequences of serotonin reuptake blockade. Neuropsychopharmacology 29, 1782 1789.
16. 3 receptors: a role in the antidepressant response. Curr. Drug Targets 7, 165 175.
17. Gibaldi M. Perrier D. (1975) The trapezoid rule, in Pharmacokinetics (Gibaldi M. Perrier D., eds pp. 293 296. Marcel Dekker, New York.
18. Gould G. G., Altamirano A. V., Javors M. A. Frazer A. (2006) A comparison of the chronic treatment effects of venlafaxine and other antidepressants on serotonin and norepinephrine transporters. Biol. Psychiatry 59, 408 414.
19. 1A receptor knockout mice. Neuropsychopharmacology 31, 2162 2172.
20. 1A receptor-induced inhibition of 5-HT neuronal activity in the rat. Br. J. Pharmacol. 126, 1741 1750.
21. 1A receptor deletion upon basal and fluoxetine-evoked 5-HT concentrations as revealed by in vivo microdialysis. Brain Res. 902, 11 17.
22. Heisler L. K., Pronchuk N., Nonogaki K. et al. (2007) Serotonin activates the hypothalamic-pituitary-adrenal axis via serotonin 2C receptor stimulation. J. Neurosci. 27, 6956 6964.
23. Hill M. N. Gorzalka B. B. (2005) Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behav. Pharmacol. 16, 333 352.
24. 1A autoreceptor desensitization by chronic ultramild stress in mice. Neuroreport 10, 3369 3374.
25. Lanfumey L., Mannoury la Cour C., Froger N. Hamon M. (2000) 5-HT-HPA interactions in two models of transgenic mice relevant to major depression. Neurochem. Res. 25, 1199 1206.
26. 1B receptors and 5-HT transporter in rats treated chronically with fluoxetine. Neuropharmacology 39, 110 122.
27. 1 receptor knockout mice. Science 283, 401 404.
28. Lesch K. P. Mössner R. (2006) Inactivation of 5-HT transport in mice: modeling altered 5-HT homeostasis implicated in emotional dysfunction, affective disorders, and somatic syndromes. Handb. Exp. Pharmacol. 175, 417 456.
29. 1A) receptor-mediated hypothermic response to ipsapirone in unipolar depression. Life Sci. 46, 1271 1277.
30. López-Giménez J. F., Tecott L. H., Palacios J. M., Mengod G. Vilaró M. T. (2002) Serotonin 5-HT (2C) receptor knockout mice: autoradiographic analysis of multiple serotonin receptors. J. Neurosci. Res. 67, 69 85.
31. Lowry O. H., Rosebrough N. J., Farr A. L. Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265 275.
32. Maldonado R., Valverde O. Berrendero F. (2006) Involvement of the endocannabinoid system in drug addiction. Trends Neurosci. 29, 225 232.
33. Mangieri R. A. Piomelli D. (2007) Enhancement of endocannabinoid signaling and the pharmacotherapy of depression. Pharmacol. Res. 56, 360 366.
34. Marsicano G., Wotjak C. T., Azad S. C. et al. (2002) The endogenous cannabinoid system controls extinction of aversive memories. Nature 418, 530 534.
35. 1 cannabinoid receptors in emotional behavior. Psychopharmacology (Berl) 159, 379 387.
36. 2A/C receptors. J. Neurochem. 103, 2111 2120.
37. Moreira F. A. Lutz B. (2008) The endocannabinoid system: emotion, learning and addiction. Addict. Biol. 13, 196 212.
38. Nichols D. E. Nichols C. D. (2008) Serotonin receptors. Chem. Rev. 108, 1614 1641.
39. Nutt D. J. (2002) The neuropharmacology of serotonin and noradrenaline in depression. Int. Clin. Psychopharmacol. 17, S1 12.
40. Olivier J. D., Van Der Hart M. G., Van Swelm R. P., Dederen P. J., Homberg J. R., Cremers T., Deen P. M., Cuppen E., Cools A. R. Ellenbroek B. A. (2008) A study in male and female 5-HT transporter knockout rats: an animal model for anxiety and depression disorders. Neuroscience 152, 573 584.
41. Parrish J. C. Nichols D. E. (2006) Serotonin 5-HT(2A) receptor activation induces 2-arachidonoylglycerol release through a phospholipase c-dependent mechanism. J. Neurochem. 99, 1164 1175.
42. Paxinos G. Franklin K. B. J. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic Press, San Diego, CA.
43. Pompeiano M., Palacios J. M. Mengod G. (1994) Distribution of the serotonin 5-HT2 receptor family mRNAs: comparison between 5-HT2A and 5-HT2C receptors. Brain Res. Mol. Brain Res. 23, 163 178.
44. 1 knockout mice. Psychopharmacology (Berl) 176, 223 232.
45. 2C receptors in GABAergic cells of the anterior raphe nuclei. J. Chem. Neuroanat. 29, 83 91.
46. Sharp T., Boothman L., Raley J. Quérée P. (2007) Important messages in the 'post': recent discoveries in 5-HT neuron feedback control. Trends Pharmacol. Sci. 28, 629 636.
47. Shippenberg T. S., He M. Chefer V. (1999) The use of microdialysis in the mouse: conventional versus quantitative techniques. Psychopharmacology (Berl) 147, 33 34.
48. Szabo B. Schlicker E. (2005) Effects of cannabinoids on neurotransmission. Handb. Exp. Pharmacol. 168, 327 65.
49. Trigo J. M., Renoir T., Lanfumey L., Hamon M., Lesch K. P., Robledo P. Maldonado R. (2007) 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol. Psychiatry 62, 669 679.
50. 1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions. Br. J. Pharmacol. 138, 544 553.
51. Valverde O. (2005) Participation of the cannabinoid system in the regulation of emotional-like behavior. Curr. Pharm. Des. 11, 3421 3429.
52. Vandermaelen C. P. Aghajanian G. K. (1983) Electrophysiological and pharmacological characterization of serotonergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res. 289, 109 119.